Clover Biopharma Gets Critical Cash Booster After Covid Vaccine Approval
The innovative drug maker announced a major share sale a day after its self-developed Covid-19 vaccine got the green light for emergency use in ChinaKey Takeaways:Clover Biopharmaceuticals raised $64 million…
